Endocardium


Also found in: Dictionary, Thesaurus, Medical, Wikipedia.

endocardium

[‚en·dō′kärd·ē·əm]
(anatomy)
The membrane lining the heart.

Endocardium

 

the endothelial lining membrane of the heart, folds of which form the cardiac valves. Inflammation of the endocardium is called endocarditis.

References in periodicals archive ?
Among chronic disease of the endocardium decedents, the PMRs for nine occupation categories were significantly above 1.
Markedly dilated atria and thickening of the ventricular endocardium, with obliteration of both apices, were noted.
The anti-inflammatory and antioxidant effect of HDLc in NAT Group was visualized by the decrease in the immunoreactive area to CD40L in the aorta and myocardium / endocardium of these animals.
According to Toshiba, the systems deliver detail and resolution throughout the entire field-of-view, providing excellent definition of the endocardium, which results in an accurate and easy-to-use 2D strain resolution.
1 Other methods involve septum of inlet formed by cushions of endocardium.
The TactiCath Quartz ablation catheter is meant to provide electrophysiologists the ability to monitor the amount of pressure that a catheter tip exerts on the endocardium (the layer of tissue that lines the chambers of the heart).
Lumason helps a physician see a patient s heart more clearly, allowing for clearer imaging of the left ventricle chamber and the smooth edge on the inside of the chambers of the heart, known as the endocardium.
eNOS activity may be affected by the mechanical strain of the endocardium due to the three-dimensional changes of the inner wall during the cardiac cycle.
From a TCM point of view, VMC can be caused by externally contracted warm-heat toxic evil or by trauma, which in turn, whenever the right Qi is insufficient, can damage the myocardium and the endocardium.
In the systolic and diastolic phases of heartbeat, two contour lines were drawn to delineate the endocardium and epicardium.
STOP-HF is an exploratory Phase 2 study of 93-patients in a double-blind, randomized, placebo-controlled trial being conducted at 15 centers in the United States to evaluate safety and efficacy of a single treatment of JVS-100, a plasmid stromal cell-derived factor 1 (SDF-1) delivered via injection to the endocardium and myocardium of patients with ischemic heart failure.
STOP-HF is an exploratory Phase 2 study of 93-patients in a double-blind, randomized, placebo-controlled trial being conducted at 15 centers in the United States to evaluate safety and efficacy of a single treatment of JVS-100, a plasmid stromal cell derived factor 1 (SDF-1) delivered via injection to the endocardium and myocardium of patients with ischemic heart failure.